Medison Ventures is a venture capital and private equity firm investing in pharmaceutical, biotechnology, and digital healthcare companies that is headquartered in Tikva, Israel and was founded in 2016 by Meir Jakobsohn. Medison Ventures in the corporate venture capital arm of Medison, a commercial partner for global pharma companies in Israel, Canada, and CEE markets. All companies receiving investment from Medison Ventures gain access to the scientific, commercial, regulatory, and clinical knowledge of Medison. These companies also gain access to the global pharma partners of Medison such as Biogen, Vertex, Shire, Biomarin, IPSEN, Servier, PTC Therapeutics, and Daiichi-Sankyo.
Notable investments made by Medison Ventures include: Keros Therapeutics, Eloxx Pharmaceuticals, AlphaTAU, Apeiron Biologics, Allogene Therapeutics, Orchard Therapeutics, and ArQule.
Venture debt fund
In 2019 Medison Ventures and Pontifax launched a venture debt fund with $150 million in funding to provide clinical-stage life science companies with non-dilutive funding.
Documentaries, videos and podcasts